Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 May;9(3):792-800.
doi: 10.1111/andr.12966. Epub 2021 Jan 19.

Neutral effect of exenatide on serum testosterone in men with type 2 diabetes mellitus: A prospective cohort

Sky Graybill  1 , Jennifer Hatfield  1 , Maria Kravchenko  1 , Darrick Beckman  2 , Joshua Tate  3 , Alexis Beauvais  4 , Philip Clerc  1 , Desarae Davila  2 , Whitney Forbes  2 , Jana Wardian  2 , Matthew Kemm  1 , Abegail Hubberd  2 , Mark True  1
Affiliations
Free article
Observational Study

Neutral effect of exenatide on serum testosterone in men with type 2 diabetes mellitus: A prospective cohort

Sky Graybill et al. Andrology. 2021 May.
Free article

Abstract

Background: Endogenous testosterone increases with weight loss from diet, exercise, and bariatric surgery. However, little is known about testosterone levels after weight loss from medication.

Objectives: Uncover the effects of Glucagon-Like Peptide-1 receptor agonist (GLP-1 RA) therapy on serum testosterone.

Material and methods: Prospective cohort study of men starting GLP-1 RA therapy for type 2 diabetes mellitus.

Results: 51 men lost 2.27 kg (p = 0.00162) and their HbA1c values improved by 0.7% (p = 0.000503) after 6 months of GLP-1 RA therapy. There was no significant change in testosterone for the group as a whole. However, in subgroup analyses, there was a significant difference in total testosterone change between men starting with baseline total testosterone <320 ng/dL (238.5 ± 56.5 ng/dL to 272.2 ± 82.3 ng/dL) compared to higher values (438 ± 98.2 ng/dL to 412 ± 141.2 ng/dL) (p = 0.0172);free testosterone increased if the baseline total testosterone was <320 ng/dL (55.2 ± 12.8 pg/mL to 57.2 ± 17.6 pg/mL) and decreased if >320 ng/dL (74.7 ± 16.3 pg/mL to 64.2 ± 17.7 pg/mL) (p = 0.00807). Additionally, there were significant differences in testosterone change between men with HbA1c improvements ≥1% (351.6 ± 123.9 ng/dL to 394.4 ± 136.5 ng/dL) compared to men with HbA1c changes <1% (331.8 ± 128.6 ng/dL to 316.1 ± 126.2 ng/dL) (p = 0.0413).

Conclusion: GLP-1 RA therapy improves weight and HbA1c without adverse effects on testosterone. Those starting with lower testosterone values or attaining greater improvement in HbA1c may see additional benefits.

Keywords: glucagon-like peptide-1; hypogonadism; testosterone.

PubMed Disclaimer

References

REFERENCES

    1. Ponce OJ, Spencer-Bonilla G, Alvarez-Villalobos N, et al. The efficacy and adverse events of testosterone replacement therapy in hypogonadal men: a systematic review and meta-analysis of randomized, placebo-controlled trials. J Clin Endocrinol Metab. 2018;103(5):1745-1754.
    1. Cole AP, Hanske J, Jiang W, et al. Impact of testosterone replacement therapy on thromboembolism, heart disease and obstructive sleep apnoea in men. BJU Int. 2018;121(5):811-818.
    1. Loo SY, Azoulay L, Nie R, Dell’Aniello S, Yu OH, Renoux C. Cardiovascular and cerebrovascular safety of testosterone replacement therapy among aging men with low testosterone levels: a cohort study. Am J Med. 2019;132:1069-1077.
    1. Vigen R, O'Donnell CI, Barón AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013;310(17):1829-1836.
    1. Goodman N, Guay A, Dandona P, Dhindsa S, Faiman C, Cunningham GR. AACE reproductive endocrinology scientific committee. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of Testosterone and Cardiovascular Risk. Endocr Pract. 2015;21(9):1066-1073.

Publication types

LinkOut - more resources